longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge
© 2026 Longbridge|Terms of ServicePrivacy Policy

Marinus Pharma

MRNS

0.55000.00% ( 0.0000 )
Delisted: Sep 22, 09:20:00 (EDT)
Start trading
OverviewOverviewOptionsOptionsNewsNewsPostsPostsFinancialsFinancialsForecastForecastValuationValuationShareholdersShareholdersProfileProfile
LongbridgeAI
  • 9 Health Care Stocks Whale Activity In Today’s Session

    benzinga_article·Sep 18 at 05:35 PM
    MRNS0.00%AMGN+4.16%
  • MRNA, SPCX, MSTR and More: 5 Stocks Investors Couldn't Stop Buzzing About This Week

    benzinga_article·Aug 21 at 10:00 PM
    - Retail investors heavily discussed five stocks between August 17 and August 21, driven by earnings, corporate news, and market momentum on social platforms. - Key market activities included Moderna announcing positive Phase 3 cancer vaccine results, Walmart reporting strong Q2 revenue of $187.9 billion, and Strategy maintaining steady Bitcoin holdings of 840,447 BTC. - Broadcom faced competitive pressures from Marvell's custom AI chip deal, while SpaceX experienced share price adjustments following a major unlock of approximately 319 million shares.
    STRD-0.33%STRF+0.30%
  • MarketBeat Week in Review – 06/29 - 07/03

    Market Beat·Jul 4 at 11:00 AM
    - Stocks closed the week positively despite a weaker June jobs report, with major indexes likely finishing higher. - The technology sector showed internal rotation, with chipmakers leading early and renewed interest in software stocks, as second-quarter earnings reports are anticipated. - Attention is shifting to small-cap opportunities like AirJoule Technologies, while analysts also highlighted potential rebound stories in firms like SanDisk and Palantir as investor sentiment stabilizes.
    MRNA+5.87%TSLA+1.04%
  • Moderna mRNA flu vaccine to get FDA panel review

    Thehill·May 21 at 02:05 PM
    MRNA+5.87%BBH+1.88%
  • Here's how much Moderna's stock has rallied off renewed focus on hantavirus research

    MarketWatch·May 11 at 05:17 PM
    MRNS0.00%MRNA+5.87%
  • Moderna (MRNA) Stock Surges 14% on Hantavirus Vaccine. Here's What Investors Should Know

    Tip Ranks·May 8 at 06:07 PM
    MRNA+5.87%BBH+1.88%
  • Key facts: Moderna automation boosts production; Q1 2026 loss $1.34B

    TradingView·May 2 at 08:03 PM
    MRNA+5.87%MRNS0.00%
  • Moderna to Present at Upcoming Conferences in May 2026 | MRNA Stock News

    StockTitan·Apr 21 at 03:01 AM
    MRNA+5.87%MRNS0.00%
  • FDA shares guide on genome editing best practices

    Pharmaceutical Technology·Apr 15 at 03:03 PM
    NTLA+3.64%DNABW0.00%
  • Marksans Pharma jumps 8% on USFDA nod for cough relief drug

    Business Standard·Mar 31 at 11:26 PM
    BIB+3.81%IXJ+0.46%
  • Globant Taps AI Cancer Research And Payments Deals As Shares Lag Targets

    Simplywall·Mar 20 at 02:32 PM
    BMRN-0.59%XLV+0.66%
  • Roivant Sciences Director Makes Major Insider Move With Eye-Catching Stock Sale

    Tip Ranks·Mar 19 at 02:08 AM
    MRNA+5.87%LABU+7.49%